Ultragenyx Pharmaceutical Inc. buy Evercore ISI
Start price
06.06.23
/
50%
€48.20
Target price
06.06.24
€74.95
Performance (%)
-20.33%
End price
07.06.24
€38.40
Summary
This prediction ended on 07.06.24 with a price of €38.40. The price of Ultragenyx Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.33%. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 3.922% | 3.922% | -29.801% |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
Comments by Evercore_ISI for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $80.00 price target on the stock, up previously from $60.00.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten